News
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as potential vision loss.
Peripheral Neuropathy Treatment Market Landscape 2025-2029: Robust Drug Pipeline to Expand the Market by $481 Million Research and Markets Fri, Jun 6, 2025, 10:17 AM 3 min read ...
Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...
June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...
A quartet of new medications may improve care of patients with hypertension, urinary tract infections (UTIs), hot flashes, and liver disease, said Gerald W. Smetana, MD, professor of medicine at ...
Pain researchers have dug 100 years into the past to work toward a better future for people with diabetic neuropathy. Researchers at The University of Texas at Dallas have shown a signature ...
A phenomenon largely ignored since its discovery 100 years ago appears to be a crucial component of diabetic pain, according to new research from The University of Texas at Dallas’ Center for Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results